Organisation: FDA Oncologic Drugs Advisory Committee

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

GlaxoSmithKline says Bexxar cancer drug gets strong support

GlaxoSmithKline PLC and Corixa Corp said a US Food and Drug Administration panel strongly supported their radioimmunotherapy drug Bexxar, which the two companies are jointly developing.

Wed, 18 Dec, 2002

Organisation: FDA Oncologic Drugs Advisory Committee

GlaxoSmithKline says Bexxar cancer drug gets strong support

Latest

Mick Clifford

Organisation: FDA Oncologic Drugs Advisory Committee

GlaxoSmithKline says Bexxar cancer drug gets strong support

Latest

Mick Clifford

Most Read